Shaf QIC LLC - 29 Jul 2025 Form 3 Insider Report for ProMIS Neurosciences Inc. (PMN)

Reporting relationship: 10%+ Owner
Issuer ticker: PMN
Reported as of: 29 Jul 2025
Net transaction value: $0
SEC form: 3
Accepted by SEC: 14 Aug 2025, 16:40:46 UTC
Source filing: View source filing
Reporting owner signature: /s/ Bill Blackett, Attorney-in-Fact

Key filing fact

Shaf QIC LLC filed Form 3 for ProMIS Neurosciences Inc. (PMN) on 14 Aug 2025.

Key facts

This page summarizes Shaf QIC LLC's Form 3 filing for ProMIS Neurosciences Inc. (PMN).
0 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 14 Aug 2025, 16:40.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (2)

CIK 0002038058 Primary reporting owner

Shaf QIC LLC

Relationship: 10%+ Owner
Address: 158 SHATTUCK WAY, NEWINGTON
Signature: /s/ Bill Blackett, Attorney-in-Fact
Signature date: 14 Aug 2025

CIK 0002081524

Shafmaster Jonathan

Relationship: 10%+ Owner
Address: 158 SHATTUCK WAY, NEWINGTON
Signature: /s/ Bill Blackett, Attorney-in-Fact
Signature date: 14 Aug 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PMN holding

Common Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 5,184,760
Date: 29 Jul 2025
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PMN holding Derivative

Warrants (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 29 Jul 2025
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 100,000
Exercise price: $7.50
Footnotes: F1

PMN holding Derivative

Warrants (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 29 Jul 2025
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 1,063,830
Exercise price: $1.75
Footnotes: F2

PMN holding Derivative

Warrants (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 29 Jul 2025
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 4,186,049
Exercise price: $1.25
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents Common Shares issuable upon exercise of a warrant that is currently exercisable.

Footnote F2

Represents Common Shares issuable upon exercise of warrants that are currently exercisable. The reported warrants contain provisions preventing their exercise to the extent that such exercise would result in the holder (together with its affiliates) obtaining greater than 9.99% of the Issuer's Common Shares.

SEC remarks

Exhibit 24 - Power of Attorney